Transferring Materials Into And Out Of UW
FAQ - Material Transfer Agreements
A Material Transfer Agreement (MTAs) is a contract that protects your intellectual property (IP) when you either provide or receive research materials to and from other institutions or corporate entities. Research materials include cell lines, cultures, bacteria, nucleotides, proteins, transgenic animals, pharmaceuticals, or chemicals. Each exchange of research material requires an MTA. For repeated exchanges of the same research material, standardized MTAs can help streamline the process. CoMotion’s Agreements Group can help you efficiently transfer research materials.
Research materials that require MTAs are cell lines, cultures, transgenic animals, and pharmaceuticals, among others.
MTAs are important because they protect UW intellectual property rights, limit UW liability, and fairly credit the developer of the materials.
The Agreements Group within the UW Center for Commercialization manages most MTAs for the UW. If the MTA is embedded in a Sponsored Research Agreement, or is linked to a clinical trial, then the Office of Sponsored Programs (OSP) may be responsible for the MTA. The UW Center for Commercialization and OSP are the only units of the University authorized to review and sign MTAs.
Outgoing not-for-profit MTAs
Outgoing for-profit MTAs
Transfer of Human Biological Materials